Key stats
About ProShares UltraShort Nasdaq Biotechnology
Expense ratio
0.95%
Home page
Inception date
Apr 7, 2010
BIS is one available fund that provides exposure to the biotech space aiming for daily geared inverse (-2x) exposure to the NASDAQ Biotechnology Index (comprised of companies that are classified as either biotechnology or pharmaceutical). The fund expects to typically hold derivatives and money market instruments. Note: BIS is a tactical tool, it is not a buy-and-hold investment and should not be expected to provide index leverage returns greater than a one-day period.
Classification
What's in the fund
Exposure type
Cash
Government
Bonds, Cash & Other100.00%
Cash57.65%
Government42.35%
Displays a symbol's price movements over previous years to identify recurring trends.